Thus, a potential new a therapy could be really successful if retains the efficacy and the discrimination capability among healthy and cancer cells, provided by CLIC1 localization, and the ability to block tmCLIC1, as metformin, but acting at lower doses. The gene discussed is CLIC1; the disease is cancer.